SCHEMBL23058746

SCHEMBL23058746

CCCCN(C(C)c1ccc(C(=O)OC)cc1)[C@@H](C)CC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 1/20 0.42
CASP1 P29466 1/20 0.42
RAB9A P51151 1/20 0.42
CYP2C9 P11712 6/20 0.42
CYP2C19 P33261 6/20 0.42
CYP3A4 P08684 6/20 0.42
CYP2D6 P10635 1/20 0.42
STAT3 P40763 1/20 0.40
MGLL Q99685 1/20 0.40
TSHR P16473 6/20 0.40
CYP1A2 P05177 4/20 0.40
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
LPAR1 Q92633 1/20 0.39
LPAR5 Q9H1C0 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23058147 0.76 THRA (0.33) SLC6A2SLC6A3MAPT
SCHEMBL23058476 0.75 NPSR1 (0.36) MAPK1GAAMAPT
SCHEMBL14640215 0.75 MGLL (0.49) NPC1CASP1RAB9ACYP2C9CYP2C19
SCHEMBL1765662 0.74 NPC1 (0.50) NPC1CASP1RAB9ACYP2C9CYP2C19
SCHEMBL23058148 0.73 MAPT (0.35) MAPT
SCHEMBL1765677 0.73 MGLL (0.50) NPC1CASP1RAB9ACYP2C9CYP2C19
SCHEMBL28291146 0.73 MGLL (0.50) L3MBTL1NPC1CASP1RAB9ACYP2C9
Hexane SCHEMBL28004600 0.73 MGLL (0.63) NPC1CASP1RAB9ACYP2C19CYP2D6
SCHEMBL23058738 0.72 PPARA (0.50) CYP3A4TSHRCYP1A2MAPK1SMN1; SMN2
SCHEMBL23058181 0.72 PDE2A (0.39) CYP2C9CYP2C19CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021041588-A1 SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-03-04 WO disclosed